Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments

Clinical trial NCT06124677 · COMPLETED

Trial details

NCT number: NCT06124677
Sponsor: Rigshospitalet, Denmark
Status: COMPLETED
Study type: OBSERVATIONAL

Neovascular Age-related Macular Degeneration

Start date: 2023-11-01
Primary completion: 2023-11-15
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.